Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN Polls

Related to Phase III Trial Finds Pfizer’s Axitinib Better than Sorafenib at Boosting PFS in Renal Cell Cancer

  • Page 1 of 1 (1 items) 1 

GEN Poll

More » Poll Results » Archive »

The Price of BRCA Testing

Is getting a genetic test worth the multi-thousand dollar price?

Suggest a Poll